Dr. Raquel Cortes, Dr Javier Perez-Hernandez, Dr. Ana Ortega are organizing this Special Issue in Pharmaceutics (MDPI) and is open for submissions until 20th November 2021
Read MoreEnhorabuena a Hector por el apoyo de la FUndación BBVA a su proyecto para el desarrollo de nuevos ensayos de biopsia liquida en melanoma. Héctor Peinado Selgas, jefe de grupo en el Centro Nacional de Investigaciones Oncológicas (CNIO). “Análisis de la mutación BRAF en exomas circulantes de pacientes de melanoma”. Subárea: Investigación traslacional. https://www.redleonardo.es/noticias/adjudicadas-58-becas-leonardo-a-investigadores-y-creadores-culturales-en-9-areas-de-la-ciencia-y-la-cultura/
Read MoreA TeNTaCLES collaboration between Yáñez-Mó and Peinado´s groups. Discover how: Tetraspanins are much more than EV markers Plasma membrane is an important source for EV cargo EV biogenesis impacts on mitochondrial quality control Biomedical potential of tetraspanin-targeted blocking peptides in tumor growth All the details at http://doi.org/10.1002/jev2.12082
Read MoreLa investigadora Mª Jesús Vicent Docón, investigadora en polímeros terapéuticos ha sido premiada en la categoría de Comunitat Valenciana. El Ayuntamiento de Picanya entregó los galardones el viernes 28 de Mayo , coincidiendo con el Día Internacional de Acción por la Salud de las Mujeres. Esta tercera edición de los galardones se ha enfocado a […]
Read MoreA TeNTaCLES collaboration between Yáñez-Mó and Peinado´s groups. Discover how: Tetraspanins are much more than EV markers Plasma membrane is an important source for EV cargo EV biogenesis impacts on mitochondrial quality control Biomedical potential of tetraspanin-targeted blocking peptides in tumor growth All the details at http://doi.org/10.1002/jev2.12082
Read MoreAlzheimer’s disease (AD), the most prevalent form of dementia, remains incurable mainly due to our failings in the search for effective pharmacological strategies. Here, we describe the development of targeted multimodal polypeptide-based nanoconjugates as potential AD treatments. Treatment with polypeptide nanoconjugates bearing propargylamine moieties and bisdemethoxycurcumin or genistein afforded neuroprotection and displayed neurotrophic effects, as […]
Read More